Application of coptis astragalus scutellaria composition in preparation of drug for preventing and treating diabetic complication
A composition and technology of astragalus polysaccharide are applied to the effective part composition of Huanglian, Astragalus and Scutellaria baicalensis, the application field in preventing and treating diabetic complications, and can solve the problems that have not been seen before.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0013] Embodiment 1 prepares pharmaceutical composition clinical commonly used preparation
[0014] According to the weight percentage, the total alkaloids of Coptidis rhizome, polysaccharides of astragalus and total flavonoids of scutellaria baicalensis are taken, and the weight percentage of compatibility thereof is 1:1:1 or 2:2:1 or 1:2:1. The common clinical preparations of the pharmaceutical composition are prepared according to conventional methods, and the dosage forms of the pharmaceutical composition preparation include oral solid preparations such as granules, tablets and capsules.
Embodiment 2
[0016] 1. In vitro experiment: Inhibitory effect of Coptidis Astragalus and Scutellaria baicalensis composition on non-enzymatic reactions and their end products
[0017] (1) Materials
[0018] Bovine serum albumin (BSA) was purchased from Shanghai Boao Biotechnology Co., Ltd., batch number 080325; D-glucose, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, nitro blue tetrazolium chloride (NBT) , sodium azide was purchased from Sinopharm Group Chemical Reagent Co., Ltd., batch numbers were F20050712, F20080619, F20070810, F20080114, F20080408; sodium carbonate and sodium bicarbonate were purchased from Shanghai Hongguang Chemical Factory, batch numbers were 071014, 080212; metformin hydrochloride tablets Purchased from Shanghai Huashi Pharmaceutical Co., Ltd., batch number 071113; 1-deoxy-1-morpholine fructose (DMF) was purchased from Sigma Company, batch number 011H4030.
[0019] (2) Method
[0020] 1 The establishment of in vitro protein NEG syste...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com